Oppenheimer analyst Francois Brisebois reiterated a Buy rating on Flexion Therapeutics (FLXN) yesterday and set a price target of $15.00.
The post Oppenheimer Thinks Flexion Therapeutics Stock is Going to Recover appeared first on Smarter Analyst.
Oppenheimer analyst Francois Brisebois reiterated a ...

https://www.smarteranalyst.com/new-blurbs/oppenheimer-thinks-flexion-therapeutics-stock-is-going-to-recover/

#SmarterAnalyst